FRIDAY, Dec. 9, 2016 -- Women on breast cancer drugs called aromatase inhibitors may show signs of early blood vessel damage that could lead to heart disease, a small study suggests.
Researchers found that compared with healthy women their age, women on aromatase inhibitors were more likely to show signs of "endothelial dysfunction." That refers to problems in how the blood vessel lining responds to blood flow.
...
Still, the study adds to evidence linking aromatase inhibitors to elevated risks of high blood pressure, high cholesterol and possibly full-blown heart disease.
Breast cancer drugs tied to blood vessel damage, heart disease
Of course, the problem is they have breast cancer and are lowering their estrogen a lot, they don't say how low, but no doubt it's very low.